Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 1, 2008
April 22, 2024
fdf54353-36d9-4ac5-9115-08d310cb7de6
Related Documents
Collection of Platelets by Automated Methods: Guidance for Industry and FDA Review Staff
Guidance DocumentDecember 1, 2007Center for Biologics Evaluation and Research
Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines: Guidance for Industry
Guidance DocumentMay 31, 2007Center for Biologics Evaluation and Research
Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs: Guidance for Industry
Guidance DocumentJune 1, 2007Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox